| Substances appearing to the Ministers to be substances which, as described in article 3 of this order, are not themselves medicinal products but which are used as ingredients in the manufacture of medicinal products | Circumstances in which the order applies to the substances referred to in Column 1 |
| 1. Amphotericin B | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 2. Bacitracin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 3. Capreomycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 4. Colistin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 5. Erythromycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 6. Gentamicin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 7. Heparin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 8. Hyaluronidase | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 9. Kanamycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 10. Neomycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 11. Penicillin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 12. Polymyxin B | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 13. Preparations of the pituitary (posterior lobe) | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 14. Streptomycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 15. The lincomycins | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 16. The rifamycins | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 17. The tetracyclines | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 18. Vancomycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 19. Viomycin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for parenteral injection into human beings or animals. |
| 20. Oxytetracycline | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product which is to be administered to human beings or animals by means other than parenteral injection. |
| 21. Tetracycline |
| Substances appearing to the Ministers to be substances which, as described in article 3 of this order, are not themselves medicinal products but which are used as ingredients in the manufacture of medicinal products | Circumstances in which the order applies to the substances referred to in Column 1 |
| 22. Dextrans | When manufactured, assembled, sold, supplied, imported or exported for use as ingredients of dextran injections for human or animal use. |
| 23. Antigens | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 24. Antisera | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 25. Antitoxins | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 26. Chorionic gonadotrophin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 27. Corticotrophin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 28. Follicle-stimulating hormone | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 29. Insulin | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 30. Sera | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 31. Streptodornase | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 32. Streptokinase | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 33. Toxins | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 34. Vaccines | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human or animal use. |
| 35. Preparations of blood | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for human use. |
| 36. Plasma | When manufactured, assembled, sold, supplied, imported or exported for use as an ingredient in a medicinal product for administration to animals. |
| 37. Any substances wholly or partly derived from animals not being substances specifically mentioned in any of the above paragraphs of this column. |